Social Media Ideas for Pharmaceuticals Industry

<![CDATA[The Industry’s Communication and Engagement with FDA]]>

Pharma industry body scouts for Indian suppliers as US faces cancer drug shortage

 Industry body reaches out to members for information on ifosfamide manufacturing capacity amid shortage in the United States

<![CDATA[Additive Manufacturing's Application in Pharma and Biotech]]>

<![CDATA[Pharma at a Political Crossroads]]>

<![CDATA[The Industry's Interest in Vaccine Platforms]]>

<![CDATA[Parabilis Medicines Raises $670 Million in Initial Public Offering ]]>

<![CDATA[What Pharma Investors Should Expect in the Current Regulatory Environment]]>

<![CDATA[Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO]]>

<![CDATA[How Pharma is Adjusting Strategies for Changing Dynamics at FDA]]>

<![CDATA[Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner]]>

<![CDATA[The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market]]>

Japan pharma companies turn to China for drug discovery, growth

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>

<![CDATA[Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO]]>

<![CDATA[Rethinking Pharma's Go-to-Market Formula]]>

<![CDATA[How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026]]>

<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>

Post-pandemic shift sees pharma firms expand focus on healthcare access

The COVID-19 pandemic may have subsided, but its impact continues to influence India's healthcare landscape, driving pharmaceutical companies to expand their role beyond medicine m...

<![CDATA[Targeted Onshoring's Impact on Domestic Pharma Manufacturing]]>

<![CDATA[Improving Global Pharma Operations with Data]]>

<![CDATA[Industrializing Machine Learning and Artificial Intelligence in Life Sciences]]>

How Indian Pharma Companies Are Strengthening Domestic Healthcare Access Post-Pandemic

The COVID-19 pandemic highlighted the importance of resilient healthcare systems, reliable medicine supply chains, and accessible healthcare solutions. While the immediate healthca...

<![CDATA[Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpha...

Surge in M&As driven by patent expirations 

We look at how rising acquisitions in the life science industry are being driven by patent cliffs.  The post Surge in M&As driven by patent expirations  appeared first on Labio...